TipRanks
CKD Bio Corp. (KR:063160)
:063160
South Korea Market
063160
CKD Bio Corp.
RESEARCH TOOLSreports

CKD Bio Corp. (063160) Income Statement

― Followers

CKD Bio Corp. Income Statement

Last quarter (Q2 2026), CKD Bio Corp.'s total revenue was ₩41.09B, a decrease of -0.30% from the same quarter last year. In Q2, CKD Bio Corp.'s net income was ₩-5.41B. See CKD Bio Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 160.07B₩ 171.76B₩ 160.35B₩ 156.04B₩ 142.24B
Gross Profit
₩ 26.10B₩ 35.94B₩ 5.01B₩ 16.79B₩ 13.31B
Operating Expenses
₩ 22.50B₩ 24.99B₩ 25.20B₩ 31.60B₩ 24.74B
Depreciation and Amortization
₩ 15.65B₩ 16.69B₩ 17.58B₩ 17.94B₩ 16.98B
EBITDA
₩ 19.26B₩ 31.17B₩ -1.63B₩ 2.29B₩ 5.56B
Operating Income
₩ 3.61B₩ 10.95B₩ -20.15B₩ -14.77B₩ -9.81B
Other Income/Expenses
₩ -6.57B₩ -1.74B₩ -4.04B₩ -3.78B₩ -2.56B
Pretax Income
₩ -2.97B₩ 9.22B₩ -24.20B₩ -18.59B₩ -13.36B
Net Income
₩ -2.89B₩ 8.70B₩ -24.19B₩ -16.70B₩ -6.58B
Per Share Metrics
Basic EPS
₩ -526.16₩ 1.59K₩ -4.41K₩ -3.04K₩ -1.20K
Diluted EPS
₩ -526.16₩ 1.59K₩ -4.41K₩ -3.04K₩ -1.20K
Weighted Average Shares Outstanding
 5.49M 5.49M 5.49M 5.49M 5.49M
Weighted Average Shares Outstanding (Diluted)
 5.49M 5.49M 5.49M 5.49M 5.49M
Currency in KRW

CKD Bio Corp. Earnings and Revenue History